Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

You could call it a public relations maneuver — Bayer Healthcare’s new website encouraging women to come to them with questions and advice about contraception instead of relying on biased bloggers or the Internet. The unbranded video features blindfolded women handling a rhino and trying to guess what it is. Awkward? Maybe. At the very least, BayerforWomen.com has captured the attention of Medical Marketing & Media. But, what makes Bayer a reliable source for women?

Read the rest of this entry »

The bad press surrounding Yaz birth control pills is beginning to catch up with the nation’s top selling oral contraceptive. It’s two-year-old television advertisement on YouTube featuring smiling women and floating balloons with the words “irritability’ and “moodiness” printed on them has more than 50,000 views, but the comments from viewers are less than flattering.

Read the rest of this entry »

Rebecca Anderson-Hull of Texas blames her birth control pills for damaging her brain and forcing her to need assistance walking, eating and even being understood. It happened two years ago when the 46-year-old mother of three suddenly and unexpectedly suffered a pulmonary embolism, or a blood clot in her lungs. She was rushed to the hospital but the lack of oxygen had caused massive brain damage. She will never be able to care for herself again, doctors said.

Read the rest of this entry »

Members of the Oral Contraceptive Over-the-Counter Working Group are advocating to – you guessed it – make birth control pills available for women without a prescription. But it is in the best interest for women when they can carry serious and even life-threatening risks?

Read the rest of this entry »

Women who have high blood pressure should use caution when taking birth control pills because the estrogen in oral contraceptives puts them at greater risk of developing blood clots and heart problems. High blood pressure affects about 74.5 million people in the United States age 20 and older.

Read the rest of this entry »

Bayer has dropped its patent suit in Delaware against Teva Pharmaceuticals Industries Ltd., and Barr Pharmaceuticals for infringing on its multi-million-dollar-selling oral contraceptive Yaz. Bayer had filed the lawsuit claiming TVA’s generic version of Yaz, known as Gianvi, infringed on Yaz. However, Bayer says it is maintaining its patent suit against Teva and Barr in Nevada District Court.

Read the rest of this entry »